<VariationArchive VariationID="21438" VariationName="NM_004937.3(CTNS):c.198_218del (p.Ile67_Pro73del)" VariationType="Deletion" Accession="VCV000021438" Version="22" RecordType="classified" NumberOfSubmissions="8" NumberOfSubmitters="8" DateLastUpdated="2024-07-29" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="34290" VariationID="21438">
      <GeneList>
        <Gene Symbol="CTNS" FullName="cystinosin, lysosomal cystine transporter" GeneID="1497" HGNC_ID="HGNC:2518" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="3636459" stop="3663103" display_start="3636459" display_stop="3663103" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="3539761" stop="3566396" display_start="3539761" display_stop="3566396" Strand="+" />
          </Location>
          <OMIM>606272</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004937.3(CTNS):c.198_218del (p.Ile67_Pro73del)</Name>
      <CanonicalSPDI>NC_000017.11:3648903:TATTACTATCCTTGAGCTCCC:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>17p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="3648904" stop="3648924" display_start="3648904" display_stop="3648924" variantLength="21" positionVCF="3648903" referenceAlleleVCF="ATATTACTATCCTTGAGCTCCC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="3552198" stop="3552218" display_start="3552198" display_stop="3552218" variantLength="21" positionVCF="3552197" referenceAlleleVCF="ATATTACTATCCTTGAGCTCCC" alternateAlleleVCF="A" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.3552198_3552218del" Assembly="GRCh37">
            <Expression>NC_000017.10:g.3552198_3552218del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.3648904_3648924del" Assembly="GRCh38">
            <Expression>NC_000017.11:g.3648904_3648924del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012489.2" sequenceAccession="NG_012489" sequenceVersion="2" change="g.17437_17457del">
            <Expression>NG_012489.2:g.17437_17457del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031681.3" sequenceAccession="NM_001031681" sequenceVersion="3" change="c.198_218del">
            <Expression>NM_001031681.3:c.198_218del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001026851.2" sequenceAccession="NP_001026851" sequenceVersion="2" change="p.Ile67_Pro73del">
            <Expression>NP_001026851.2:p.Ile67_Pro73del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374492.1" sequenceAccession="NM_001374492" sequenceVersion="1" change="c.198_218del">
            <Expression>NM_001374492.1:c.198_218del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001361421.1" sequenceAccession="NP_001361421" sequenceVersion="1" change="p.Ile67_Pro73del">
            <Expression>NP_001361421.1:p.Ile67_Pro73del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374494.1" sequenceAccession="NM_001374494" sequenceVersion="1" change="c.-244_-224del">
            <Expression>NM_001374494.1:c.-244_-224del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004937.3" sequenceAccession="NM_004937" sequenceVersion="3" change="c.198_218del" MANESelect="true">
            <Expression>NM_004937.3:c.198_218del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004928.2" sequenceAccession="NP_004928" sequenceVersion="2" change="p.Ile67_Pro73del">
            <Expression>NP_004928.2:p.Ile67_Pro73del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374493.1" sequenceAccession="NM_001374493" sequenceVersion="1" change="c.-217+1382_-217+1402del">
            <Expression>NM_001374493.1:c.-217+1382_-217+1402del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374495.1" sequenceAccession="NM_001374495" sequenceVersion="1" change="c.-216-6094_-216-6074del">
            <Expression>NM_001374495.1:c.-216-6094_-216-6074del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001374496.1" sequenceAccession="NM_001374496" sequenceVersion="1" change="c.-217+1382_-217+1402del">
            <Expression>NM_001374496.1:c.-217+1382_-217+1402del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001031681.2" sequenceAccession="NM_001031681" sequenceVersion="2" change="c.198_218del21">
            <Expression>NM_001031681.2:c.198_218del21</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA342073" DB="ClinGen" />
        <XRef Type="rs" ID="113994204" DB="dbSNP" />
      </XRefList>
      <AlleleFrequencyList>
        <AlleleFrequency Value="0.00000" Source="Trans-Omics for Precision Medicine (TOPMed)" />
        <AlleleFrequency Value="0.00002" Source="Exome Aggregation Consortium (ExAC)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD)" />
        <AlleleFrequency Value="0.00002" Source="The Genome Aggregation Database (gnomAD), exomes" />
      </AlleleFrequencyList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004937.3(CTNS):c.198_218del (p.Ile67_Pro73del) AND Nephropathic cystinosis" Accession="RCV000020623" Version="22">
        <ClassifiedConditionList TraitSetID="1222">
          <ClassifiedCondition DB="MedGen" ID="C2931187">Nephropathic cystinosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-11-22" SubmissionCount="4">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004937.3(CTNS):c.198_218del (p.Ile67_Pro73del) AND Cystinosis" Accession="RCV000780201" Version="11">
        <ClassifiedConditionList TraitSetID="31961">
          <ClassifiedCondition DB="MedGen" ID="C4316899">Cystinosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2018-04-09" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004937.3(CTNS):c.198_218del (p.Ile67_Pro73del) AND multiple conditions" Accession="RCV002051792" Version="11">
        <ClassifiedConditionList TraitSetID="10684">
          <ClassifiedCondition DB="MedGen" ID="C0268626">Juvenile nephropathic cystinosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2931187">Nephropathic cystinosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2931013">Ocular cystinosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-16" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_004937.3(CTNS):c.198_218del (p.Ile67_Pro73del) AND multiple conditions" Accession="RCV002513139" Version="9">
        <ClassifiedConditionList TraitSetID="65712">
          <ClassifiedCondition DB="MedGen" ID="C0950123">Inborn genetic diseases</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0268626">Juvenile nephropathic cystinosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C2931013">Ocular cystinosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-04" NumberOfSubmissions="8" NumberOfSubmitters="8" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">15128704</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18178779</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18752449</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21305353</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26489029</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28629674</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9792862</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301574</ID>
          <ID Source="BookShelf">NBK1400</ID>
        </Citation>
        <DescriptionHistory Dated="2019-05-31">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-05-29">
          <Description>Pathogenic/Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="65712" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="32761" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Inborn genetic diseases</ElementValue>
              </Name>
              <Citation Type="general" Abbrev="Langer et al., 2012">
                <ID Source="PubMed">22947299</ID>
              </Citation>
              <Citation Type="general" Abbrev="SACHDNC, 2013">
                <ID Source="PubMed">23037933</ID>
              </Citation>
              <Citation Type="general" Abbrev="EASAC/FEAM, 2013">
                <ID Source="PubMed">23169492</ID>
              </Citation>
              <Citation Type="general" Abbrev="ESHG/P3G/HUGO/PHGF, 2015">
                <ID Source="PubMed">25626707</ID>
              </Citation>
              <Citation Type="general" Abbrev="Alpha-1 Foundation, 2014">
                <ID Source="PubMed">24121147</ID>
              </Citation>
              <Citation Type="general" Abbrev="NBSTRN, 2015">
                <ID Source="PubMed">24394680</ID>
              </Citation>
              <Citation Type="general" Abbrev="EUNENBS, 2014">
                <ID Source="PubMed">23652378</ID>
              </Citation>
              <Citation Type="general" Abbrev="NSGC, 2014">
                <ID Source="PubMed">23881473</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG/ACOG/NSGC/PQF/SMFM, 2015">
                <ID Source="PubMed">25730230</ID>
              </Citation>
              <Citation Type="general" Abbrev="Skirton et al., 2014">
                <ID Source="PubMed">24022298</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23619275</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACOG, 2019">
                <ID Source="PubMed">31022120</ID>
              </Citation>
              <XRef ID="C0950123" DB="MedGen" />
              <XRef ID="D030342" DB="MeSH" />
            </Trait>
            <Trait ID="1216" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE</ElementValue>
                <XRef Type="MIM" ID="219900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Juvenile nephropathic cystinosis</ElementValue>
                <XRef ID="Juvenile+nephropathic+cystinosis/8698" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009066" DB="MONDO" />
                <XRef ID="22830006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Cystinosis comprises three allelic phenotypes: Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, affected individuals can survive at least into the mid-forties or fifties with satisfactory quality of life. Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated affected individuals, usually between ages 15 and 25 years. The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.</Attribute>
                <XRef ID="NBK1400" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17685" />
                <XRef ID="17685" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301574</ID>
                <ID Source="BookShelf">NBK1400</ID>
              </Citation>
              <XRef ID="213" DB="Orphanet" />
              <XRef ID="411634" DB="Orphanet" />
              <XRef ID="C0268626" DB="MedGen" />
              <XRef ID="MONDO:0009066" DB="MONDO" />
              <XRef Type="MIM" ID="219900" DB="OMIM" />
            </Trait>
            <Trait ID="1215" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Ocular cystinosis</ElementValue>
                <XRef ID="MONDO:0009064" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinosis, ocular nonnephropathic</ElementValue>
                <XRef ID="Cystinosis%2C+Ocular+Nonnephropathic/2080" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinosis, adult, nonnephropathic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinosis, benign, nonnephropathic</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Cystinosis comprises three allelic phenotypes: Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, affected individuals can survive at least into the mid-forties or fifties with satisfactory quality of life. Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated affected individuals, usually between ages 15 and 25 years. The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.</Attribute>
                <XRef ID="NBK1400" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9756" />
                <XRef ID="9756" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301574</ID>
                <ID Source="BookShelf">NBK1400</ID>
              </Citation>
              <XRef ID="213" DB="Orphanet" />
              <XRef ID="411641" DB="Orphanet" />
              <XRef ID="C2931013" DB="MedGen" />
              <XRef ID="MONDO:0009064" DB="MONDO" />
              <XRef Type="MIM" ID="219750" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1222" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15909" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephropathic cystinosis</ElementValue>
                <XRef ID="54105" DB="GeneTests" />
                <XRef ID="MONDO:0100151" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lysosomal cystine transport protein, defect of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinosin, defect of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Abderhalden Lignac Kaufmann disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Abderhalden-Kaufmann-Lignac syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CTNS</ElementValue>
                <XRef ID="GTR000529128" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="219800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10074" />
                <XRef ID="10074" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cystinosis comprises three allelic phenotypes: Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, affected individuals can survive at least into the mid-forties or fifties with satisfactory quality of life. Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated affected individuals, usually between ages 15 and 25 years. The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.</Attribute>
                <XRef ID="NBK1400" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301574</ID>
                <ID Source="BookShelf">NBK1400</ID>
              </Citation>
              <XRef ID="213" DB="Orphanet" />
              <XRef ID="411629" DB="Orphanet" />
              <XRef ID="C2931187" DB="MedGen" />
              <XRef ID="MONDO:0100151" DB="MONDO" />
              <XRef Type="MIM" ID="219800" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="31961" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6309" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cystinosis</ElementValue>
                <XRef ID="3377" DB="GeneTests" />
                <XRef ID="MONDO:0016239" DB="MONDO" />
                <XRef ID="190681003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystine diathesis</ElementValue>
                <XRef ID="D003554" DB="MeSH" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystine disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystine storage disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinoses</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Cystinosis comprises three allelic phenotypes: Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, affected individuals can survive at least into the mid-forties or fifties with satisfactory quality of life. Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated affected individuals, usually between ages 15 and 25 years. The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.</Attribute>
                <XRef ID="NBK1400" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6236" />
                <XRef ID="6236" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301574</ID>
                <ID Source="BookShelf">NBK1400</ID>
              </Citation>
              <XRef ID="213" DB="Orphanet" />
              <XRef ID="C4316899" DB="MedGen" />
              <XRef ID="MONDO:0016239" DB="MONDO" />
            </Trait>
          </TraitSet>
          <TraitSet ID="10684" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="15909" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Nephropathic cystinosis</ElementValue>
                <XRef ID="54105" DB="GeneTests" />
                <XRef ID="MONDO:0100151" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Lysosomal cystine transport protein, defect of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinosin, defect of</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Abderhalden Lignac Kaufmann disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Abderhalden-Kaufmann-Lignac syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CTNS</ElementValue>
                <XRef ID="GTR000529128" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000558532" DB="Genetic Testing Registry (GTR)" />
                <XRef Type="MIM" ID="219800" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10074" />
                <XRef ID="10074" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Cystinosis comprises three allelic phenotypes: Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, affected individuals can survive at least into the mid-forties or fifties with satisfactory quality of life. Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated affected individuals, usually between ages 15 and 25 years. The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.</Attribute>
                <XRef ID="NBK1400" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301574</ID>
                <ID Source="BookShelf">NBK1400</ID>
              </Citation>
              <XRef ID="213" DB="Orphanet" />
              <XRef ID="411629" DB="Orphanet" />
              <XRef ID="C2931187" DB="MedGen" />
              <XRef ID="MONDO:0100151" DB="MONDO" />
              <XRef Type="MIM" ID="219800" DB="OMIM" />
            </Trait>
            <Trait ID="1216" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">CYSTINOSIS, LATE-ONSET JUVENILE OR ADOLESCENT NEPHROPATHIC TYPE</ElementValue>
                <XRef Type="MIM" ID="219900" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0016" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0018" DB="OMIM" />
                <XRef Type="Allelic variant" ID="606272.0008" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Juvenile nephropathic cystinosis</ElementValue>
                <XRef ID="Juvenile+nephropathic+cystinosis/8698" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009066" DB="MONDO" />
                <XRef ID="22830006" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Cystinosis comprises three allelic phenotypes: Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, affected individuals can survive at least into the mid-forties or fifties with satisfactory quality of life. Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated affected individuals, usually between ages 15 and 25 years. The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.</Attribute>
                <XRef ID="NBK1400" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17685" />
                <XRef ID="17685" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301574</ID>
                <ID Source="BookShelf">NBK1400</ID>
              </Citation>
              <XRef ID="213" DB="Orphanet" />
              <XRef ID="411634" DB="Orphanet" />
              <XRef ID="C0268626" DB="MedGen" />
              <XRef ID="MONDO:0009066" DB="MONDO" />
              <XRef Type="MIM" ID="219900" DB="OMIM" />
            </Trait>
            <Trait ID="1215" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Ocular cystinosis</ElementValue>
                <XRef ID="MONDO:0009064" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinosis, ocular nonnephropathic</ElementValue>
                <XRef ID="Cystinosis%2C+Ocular+Nonnephropathic/2080" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinosis, adult, nonnephropathic</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cystinosis, benign, nonnephropathic</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Cystinosis comprises three allelic phenotypes: Nephropathic cystinosis in untreated children is characterized by renal Fanconi syndrome, poor growth, hypophosphatemic/calcipenic rickets, impaired glomerular function resulting in complete glomerular failure, and accumulation of cystine in almost all cells, leading to cellular dysfunction with tissue and organ impairment. The typical untreated child has short stature, rickets, and photophobia. Failure to thrive is generally noticed after approximately age six months; signs of renal tubular Fanconi syndrome (polyuria, polydipsia, dehydration, and acidosis) appear as early as age six months; corneal crystals can be present before age one year and are always present after age 16 months. Prior to the use of renal transplantation and cystine-depleting therapy, the life span in nephropathic cystinosis was no longer than ten years. With these interventions, affected individuals can survive at least into the mid-forties or fifties with satisfactory quality of life. Intermediate cystinosis is characterized by all the typical manifestations of nephropathic cystinosis, but onset is at a later age. Renal glomerular failure occurs in all untreated affected individuals, usually between ages 15 and 25 years. The non-nephropathic (ocular) form of cystinosis is characterized clinically only by photophobia resulting from corneal cystine crystal accumulation.</Attribute>
                <XRef ID="NBK1400" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="9756" />
                <XRef ID="9756" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301574</ID>
                <ID Source="BookShelf">NBK1400</ID>
              </Citation>
              <XRef ID="213" DB="Orphanet" />
              <XRef ID="411641" DB="Orphanet" />
              <XRef ID="C2931013" DB="MedGen" />
              <XRef ID="MONDO:0009064" DB="MONDO" />
              <XRef Type="MIM" ID="219750" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1793884" SubmissionDate="2019-04-24" DateLastUpdated="2019-06-02" DateCreated="2019-06-02">
        <ClinVarSubmissionID localKey="NM_004937.2:c.198_218del21|MedGen:C4316899" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000917267" DateUpdated="2019-06-02" DateCreated="2019-06-02" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-04-09">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">26489029</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9792862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18752449</ID>
          </Citation>
          <Comment>Variant summary: CTNS c.198_218del21 (p.Ile67_Pro73del) results in an in-frame deletion that is predicted to remove ITILELP amino acids from the encoded protein. c.198_218del21 has been reported in the literature in multiple individuals affected with Cystinosis as both a homozygous and compound heterozygous allele. These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004937.2:c.198_218del21</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cystinosis</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C4316899" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2246017" SubmissionDate="2019-10-22" DateLastUpdated="2020-01-09" DateCreated="2020-01-09">
        <ClinVarSubmissionID localKey="NC_000017.10:g.3552198_3552218delTATTACTATCCTTGAGCTCCC|OMIM:219800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001140214" DateUpdated="2020-01-09" DateCreated="2020-01-09" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-05-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2017</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.3552198_3552218delTATTACTATCCTTGAGCTCCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_020</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354693" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-03" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="117295|OMIM:219800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194238" DateUpdated="2020-07-03" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000220565" DateChanged="2020-07-01" Version="1">
            <Comment Type="MergeComment">SCV000220565 was merged into SCV001194238 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-12-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">18178779</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">9792862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21305353</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15128704</ID>
          </Citation>
          <Comment>NM_001031681.2(CTNS):c.198_218del21(aka I67_P73del) is classified as likely pathogenic in the context of cystinosis and is associated with a less severe form of disease. Sources cited for classification include the following: PMID 18178779â€šÃ„Ã¶âˆšÃ‘âˆšÂ©, 9792862, 21305353 and 15128704. Classification of NM_001031681.2(CTNS):c.198_218del21(aka I67_P73del) is based on the following criteria: There is strong evidence of association with the variant and the relevant disease. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="17" alternateAllele="A" referenceAllele="ATATTACTATCCTTGAGCTCCC" start="3552197" stop="3552218" variantLength="22" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41132" SubmissionDate="2013-03-26" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_004937.2:c.198_218del_NBK1400" title="NM_004937.2:c.198_218del and Cystinosis" />
        <ClinVarAccession Accession="SCV000041132" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">20301574</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="BookShelf">NBK1400</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="113994204" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004937.2:c.198_218del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C2931187" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5463456" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_004937.3:c.198_218del|OMIM:219750;219800;219900" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002811149" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-16">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004937.3:c.198_218del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="TraitChoice">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219750" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219800" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219900" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7867263" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2023-12-30">
        <ClinVarSubmissionID localKey="NM_004937.3:c.198_218del|OMIM:219800" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004212930" DateUpdated="2024-06-17" DateCreated="2023-12-30" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004937.3:c.198_218del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="219800" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
          <SubmissionName>SUB13856327</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4079518" SubmissionDate="2022-02-09" DateLastUpdated="2022-04-23" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_004937.3:c.198_218del|Cystinosis" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002093225" DateUpdated="2022-04-23" DateCreated="2022-04-23" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_004937.3:c.198_218del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cystinosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10993736</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4233352" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2022-03-28">
        <ClinVarSubmissionID localKey="2009162|MedGen:C0950123;C1857413;C0268626" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002215691" DateUpdated="2024-02-28" DateCreated="2022-03-28" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">9792862</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">28629674</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15128704</ID>
          </Citation>
          <Comment>This variant, c.198_218del, results in the deletion of 7 amino acid(s) of the CTNS protein (p.Ile67_Pro73del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs113994204, gnomAD 0.006%). This variant has been observed in individual(s) with cystinosis (PMID: 9792862, 28629674). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 21438). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this variant affects CTNS function (PMID: 15128704). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CTNS" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.3552198_3552218del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0950123" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1857413" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268626" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11173117</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="4233352" TraitType="Disease" MappingType="XRef" MappingValue="C0950123" MappingRef="MedGen">
        <MedGen CUI="C0950123" Name="Inborn genetic diseases" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41132" TraitType="Disease" MappingType="XRef" MappingValue="C2931187" MappingRef="MedGen">
        <MedGen CUI="C2931187" Name="Nephropathic cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354693" TraitType="Disease" MappingType="XRef" MappingValue="219800" MappingRef="OMIM">
        <MedGen CUI="C2931187" Name="Nephropathic cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4079518" TraitType="Disease" MappingType="Name" MappingValue="Cystinosis" MappingRef="Preferred">
        <MedGen CUI="C4316899" Name="Cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463456" TraitType="Disease" MappingType="XRef" MappingValue="219750" MappingRef="OMIM">
        <MedGen CUI="C2931013" Name="Ocular cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463456" TraitType="Disease" MappingType="XRef" MappingValue="219800" MappingRef="OMIM">
        <MedGen CUI="C2931187" Name="Nephropathic cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2246017" TraitType="Disease" MappingType="XRef" MappingValue="219800" MappingRef="OMIM">
        <MedGen CUI="C2931187" Name="Nephropathic cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7867263" TraitType="Disease" MappingType="XRef" MappingValue="219800" MappingRef="OMIM">
        <MedGen CUI="C2931187" Name="Nephropathic cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4233352" TraitType="Disease" MappingType="XRef" MappingValue="C0268626" MappingRef="MedGen">
        <MedGen CUI="C0268626" Name="Juvenile nephropathic cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5463456" TraitType="Disease" MappingType="XRef" MappingValue="219900" MappingRef="OMIM">
        <MedGen CUI="C0268626" Name="Juvenile nephropathic cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1793884" TraitType="Disease" MappingType="Name" MappingValue="Cystinosis" MappingRef="Preferred">
        <MedGen CUI="C4316899" Name="Cystinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4233352" TraitType="Disease" MappingType="XRef" MappingValue="C1857413" MappingRef="MedGen">
        <MedGen CUI="C2931013" Name="Ocular cystinosis" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

